The experienced retinal surgeon is familiar with the frustrating task of prognosticating and preventing/treating proliferative vitreoretinopathy (PVR) after retinal detachment (RD) surgery. The imperfection of long-described clinical models for predicting PVR leaves the surgeon questioning what underlying predispositions to PVR may exist. 1 Rojas and colleagues 2 provide insight into this question in their candidate gene association study examining inflammatory genetic markers with the occurrence of PVR after primary RD repair. In their study, Rojas et al. identified single nucleotide polymorphisms (SNPs) in the genes SMAD7 and TNF-a between subjects who developed PVR and those who did not. SMAD7 is an intracellular signaling molecule that results in the downstream inhibition of TGF-b-mediated fibrosis. It is noteworthy that this study could not replicate the previously described TGF-b association. It is very exciting to note the TNF-a association since there are approved drugs that block this proinflammatory cytokine and have even been administered intraocularly.
